Author | Ricardo H. Alvarez, MD, MSc | OncLive

Author | Ricardo H. Alvarez, MD, MSc


Dr. Alvarez on Updated Findings With Eribulin in Patients With HER2- Breast Cancer

December 13, 2016


Ricardo H. Alvarez, MD, MSc, director of Cancer Research, breast medical oncologist, Southeastern Regional Medical Center, Cancer Treatment Centers of America, discusses updated findings regarding the mechanism of action with eribulin mesylate (Halaven) and how it impacts patients with HER2-negative breast cancer.